HDAC6 and rheumatoid arthritis: To verify the therapeutic treatment of HDAC6 shRNA on RA, we constructed a CIA mouse model broadly employed to elucidate the mechanism of action of RA and to discover potential therapeutic objectives; four mice were included in each group, and the specific model construction process and the administration grouping scheme are shown in Figure 4A.